Provided by Tiger Fintech (Singapore) Pte. Ltd.

Helius Medical Technologies, Inc.

0.4116
+0.01664.20%
Post-market: 0.41560.0040+0.97%16:00 EDT
Volume:15.82K
Turnover:6.42K
Market Cap:2.34M
PE:-0.09
High:0.4226
Open:0.4024
Low:0.3950
Close:0.3950
Loading ...

Company Profile

Company Name:
Helius Medical Technologies, Inc.
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
22
Office Location:
642 Newtown Yardley Road,Suite 100,Newtown,Pennsylvania,United States
Zip Code:
18940
Fax:
- -
Introduction:
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

Directors

Name
Position
Blane Walter
Chairman of the Board
Dane C. Andreeff
Interim President and Chief Executive Officer and Director
Edward M. Straw
Director
Jeffrey S. Mathiesen
Director
Mitchell E. Tyler
Director

Shareholders

Name
Position
Dane C. Andreeff
Interim President and Chief Executive Officer and Director
Joyce LaViscount
Chief Financial Officer and Chief Operating Officer
Jonathan Sackier
Chief Medical Officer